Evidence map›Paper›PMID 30663453›Full record

ArticleInternational journal of toxicology

Safety Study of Single-Dose Intravenously Administered DOTA-Siglec-9 Peptide in Sprague Dawley Rats.

Paulina Chrusciel, Emrah Yatkin, Xiang-Guo Li, Ulla-Marjut Jaakkola, Juhani Knuuti, Sirpa Jalkanen, Anne Roivainen

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of toxicology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. First-in-Humans Study ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Paulina Chrusciel1 Central Animal Laboratory, University of Turku, Turku, Finland.
Emrah Yatkin1 Central Animal Laboratory, University of Turku, Turku, Finland.
Xiang-Guo Li2 Turku PET Centre, University of Turku, Turku, Finland.
Ulla-Marjut Jaakkola1 Central Animal Laboratory, University of Turku, Turku, Finland.
Juhani Knuuti2 Turku PET Centre, University of Turku, Turku, Finland.
Sirpa Jalkanen5 MediCity Research Laboratory, University of Turku, Turku, Finland.
Anne Roivainen2 Turku PET Centre, University of Turku, Turku, Finland.ORCID 0000-0002-4006-7977
University of Turku · FIÅbo Akademi University · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The peptide-based radioactive compound [

Indexed as

Administration, IntravenousAnimalsAntigens, CDContrast MediaFemaleHeterocyclic Compounds, 1-RingMaleRats, Sprague-DawleySialic Acid Binding Immunoglobulin-like LectinsToxicity Tests, Acute1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidAntigens, CDContrast MediaHeterocyclic Compounds, 1-RingSialic Acid Binding Immunoglobulin-like LectinsDOTA-Siglec-9 peptideextended single doseGLPPETratssafety

Identifiers

PMID30663453
PMCPMC6357174
OpenAlexW2914964066

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.